Unilever Stock May Be 23% Undervalued After Bid Interest Report

Simply Wall St··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Unilever stock may be 23% undervalued according to a Discounted Cash Flow analysis, even as the company considers a bid for Thorne valued at up to $4 billion. The DCF model estimates an intrinsic value of about £59.08 per share, roughly 23.4% above the current market price, based on a latest twelve-month free cash flow of approximately €6.8 billion and assumptions of gradually growing cash flows. In contrast, Unilever trades on a price-to-earnings ratio of about 20.0 times, close to the peer average of 20.7 times and slightly above the wider Personal Products industry at 18.5 times, suggesting the stock is roughly fairly valued on an earnings basis. Broader valuation checks show a mixed picture, with four out of six indicators flagging value, leaving investors to weigh whether the current discount reflects execution and integration risk around the potential Thorne deal or presents a margin of safety.

Impact on assets 2

Consumer Staples▲
Unilever PLC
UNLYD
▲ PositiveCapitalrelevance

DCF analysis suggests 23% undervaluation, and four of six valuation indicators flag value.

Off-coverage companies 1

Thorne HealthTech, Inc.i
Private± MixedCapitalrelevance

Unilever considers a bid for Thorne valued up to $4 billion, but deal outcome and impact on Thorne are unclear.